1. Home
  2. LUNG vs PTMN Comparison

LUNG vs PTMN Comparison

Compare LUNG & PTMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • PTMN
  • Stock Information
  • Founded
  • LUNG 1995
  • PTMN 2006
  • Country
  • LUNG United States
  • PTMN United States
  • Employees
  • LUNG N/A
  • PTMN N/A
  • Industry
  • LUNG Industrial Specialties
  • PTMN Finance: Consumer Services
  • Sector
  • LUNG Health Care
  • PTMN Finance
  • Exchange
  • LUNG Nasdaq
  • PTMN Nasdaq
  • Market Cap
  • LUNG 124.0M
  • PTMN 107.9M
  • IPO Year
  • LUNG 2020
  • PTMN N/A
  • Fundamental
  • Price
  • LUNG $2.67
  • PTMN $12.66
  • Analyst Decision
  • LUNG Buy
  • PTMN Hold
  • Analyst Count
  • LUNG 6
  • PTMN 1
  • Target Price
  • LUNG $11.53
  • PTMN $14.00
  • AVG Volume (30 Days)
  • LUNG 366.5K
  • PTMN 43.9K
  • Earning Date
  • LUNG 07-30-2025
  • PTMN 08-07-2025
  • Dividend Yield
  • LUNG N/A
  • PTMN 19.01%
  • EPS Growth
  • LUNG N/A
  • PTMN N/A
  • EPS
  • LUNG N/A
  • PTMN N/A
  • Revenue
  • LUNG $87,473,000.00
  • PTMN $58,024,000.00
  • Revenue This Year
  • LUNG $18.02
  • PTMN N/A
  • Revenue Next Year
  • LUNG $18.17
  • PTMN $12.20
  • P/E Ratio
  • LUNG N/A
  • PTMN N/A
  • Revenue Growth
  • LUNG 19.84
  • PTMN N/A
  • 52 Week Low
  • LUNG $2.62
  • PTMN $11.48
  • 52 Week High
  • LUNG $9.37
  • PTMN $19.95
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 33.53
  • PTMN 63.79
  • Support Level
  • LUNG $2.62
  • PTMN $11.54
  • Resistance Level
  • LUNG $3.52
  • PTMN $11.80
  • Average True Range (ATR)
  • LUNG 0.23
  • PTMN 0.22
  • MACD
  • LUNG 0.02
  • PTMN 0.11
  • Stochastic Oscillator
  • LUNG 13.46
  • PTMN 100.00

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About PTMN Portman Ridge Finance Corporation

Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.

Share on Social Networks: